Washington—The effectiveness of treatment for hepatitis C virus (HCV) infection appears to wane with increasing age. A new study presented at Digestive Disease Week found that patients over 70 years of age had a lower sustained virologic response (SVR) to direct-acting antivirals (DAAs) than younger patients.
The results are not good news for these elderly patients. “The highest prevalence of hepatitis C infections is estimated to be among baby boomers, a population that is